These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15721020)

  • 21. HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia.
    Oravec S; Dostal E; Dukát A; Gavorník P; Kucera M; Gruber K
    Neuro Endocrinol Lett; 2011; 32(4):502-9. PubMed ID: 21876506
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Malondialdehyde Low-Density Lipoprotein Stratified by Low-Density Lipoprotein Cholesterol.
    Moriyama K; Takahashi E
    Clin Lab; 2017 Jul; 63(7):1179-1186. PubMed ID: 28792690
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
    Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating malondialdehyde-modified low-density lipoprotein is strongly associated with very small low-density lipoprotein cholesterol concentrations in healthy men.
    Takahashi R; Imamura A; Yoshikane M; Suzuki M; Cheng XW; Numaguchi Y; Ikeda N; Murohara T; Okumura K
    Clin Chim Acta; 2009 Jan; 399(1-2):74-8. PubMed ID: 18840422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Malondialdehyde-Modified Low Density Lipoprotein as Oxidative-Stress Marker in Vasospastic Angina Patients.
    Oumi T; Nozato T; Sakakibara A; Nomoto H; Ohno M; Takahashi Y; Ashikaga T; Satoh Y; Isobe M
    Int Heart J; 2017 May; 58(3):335-343. PubMed ID: 28539572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Changes in serum malondialdehyde-modified low-density lipoprotein in patients with acute myocardial infarction and stable angina pectoris treated by coronary angioplasty].
    Araki T; Kanaya H; Shimizu M; Mabuchi H; Kitayama M; Kanemitsu S; Takekoshi N;
    J Cardiol; 2001 Aug; 38(2):55-60. PubMed ID: 11525110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneous properties of intermediate- and low-density lipoprotein subpopulations.
    Srisawasdi P; Vanavanan S; Rochanawutanon M; Pornsuriyasak P; Tantrakul V; Kruthkul K; Kotani K
    Clin Biochem; 2013 Oct; 46(15):1509-15. PubMed ID: 23830843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of plasma level of malondialdehyde-modified low-density lipoprotein with coronary plaque morphology in patients with coronary spastic angina: implication of acute coronary events.
    Tani S; Nagao K; Anazawa T; Kawamata H; Furuya S; Fuji T; Takahashi H; Iida K; Matsumoto M; Kumabe T; Sato Y; Hirayama A
    Int J Cardiol; 2009 Jun; 135(2):202-6. PubMed ID: 18614250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antibodies against modified low-density lipoproteins and their complexes in blood of patients with various manifestations of atherosclerosis].
    Belik IV; Ivantsova AA; Mamedova ZE; Denisenko AD
    Biomed Khim; 2016 May; 62(4):471-5. PubMed ID: 27563003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating electronegatively charged low-density lipoprotein in patients with angiographically documented coronary artery disease.
    Tomasik A; Jacheć W; Skrzep-Poloczek B; Widera-Romuk E; Wodniecki J; Wojciechowska C
    Scand J Clin Lab Invest; 2003; 63(4):259-65. PubMed ID: 12940633
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody titer against malondialdehyde-modified LDL compares with HDL cholesterol concentration in identifying angiographically verified coronary artery disease. Comparison of tests by ROC analysis.
    Rontu R; Metso S; Jaakkola O; Nikkilä M; Jokela H; Lehtimäki T
    Clin Chem Lab Med; 2005; 43(4):357-60. PubMed ID: 15899649
    [TBL] [Abstract][Full Text] [Related]  

  • 32. L-arginine improves endothelial function and reduces LDL oxidation in patients with stable coronary artery disease.
    Yin WH; Chen JW; Tsai C; Chiang MC; Young MS; Lin SJ
    Clin Nutr; 2005 Dec; 24(6):988-97. PubMed ID: 16140428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum cholesterol and triglyceride reference ranges of twenty lipoprotein subclasses for healthy Japanese men and women.
    Furusyo N; Ai M; Okazaki M; Ikezaki H; Ihara T; Hayashi T; Hiramine S; Ura K; Kohzuma T; Schaefer EJ; Hayashi J
    Atherosclerosis; 2013 Dec; 231(2):238-45. PubMed ID: 24267234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of postprandial lipaemia on low-density lipoprotein (LDL) size and oxidized LDL in patients with coronary artery disease.
    Granér M; Kahri J; Nakano T; Sarna SJ; Nieminen MS; Syvänne M; Taskinen MR
    Eur J Clin Invest; 2006 Nov; 36(11):764-70. PubMed ID: 17032343
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inter-relationships between small, dense low-density lipoprotein (LDL), plasma triacylglycerol and LDL apoprotein B in an atherogenic lipoprotein phenotype in free-living subjects.
    Griffin BA; Minihane AM; Furlonger N; Chapman C; Murphy M; Williams D; Wright JJ; Williams CM
    Clin Sci (Lond); 1999 Sep; 97(3):269-76. PubMed ID: 10464051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lipoprotein profile in patients who survive a stroke.
    Oravec S; Krivosikova Z; Krivosik M; Gruber K; Gruber M; Dukát A; Gavorník P
    Neuro Endocrinol Lett; 2011; 32(4):496-501. PubMed ID: 21876499
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Association between plasma adiponectin and small, dense low density lipoprotein in patients with coronary artery disease].
    Chen G; Qin Q; Li Y; Ren B; Lu YR; Kou L; Yang N; Feng JP; Zhao BR
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Sep; 40(9):752-6. PubMed ID: 23141087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Malondialdehyde-Modified Low-Density Lipoprotein on Tissue Characteristics in Patients With Stable Coronary Artery Disease　- Integrated Backscatter-Intravascular Ultrasound Study.
    Ikenaga H; Kurisu S; Kono S; Sumimoto Y; Watanabe N; Shimonaga T; Higaki T; Iwasaki T; Mitsuba N; Ishibashi K; Dohi Y; Fukuda Y; Kihara Y
    Circ J; 2016 Sep; 80(10):2173-82. PubMed ID: 27581176
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microsomal triglyceride transfer protein gene polymorphism strongly influences circulating malondialdehyde-modified low-density lipoprotein.
    Okumura K; Imamura A; Murakami R; Takahashi R; Cheng XW; Numaguchi Y; Murohara T
    Metabolism; 2009 Sep; 58(9):1306-11. PubMed ID: 19501864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effects after withdrawal of simvastatin on brachial artery endothelial function in patient with coronary heart disease or risk factors].
    Chen H; Ren JY; Wu B; Liu X; Wang RJ; Li LJ; Luo Y
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):531-5. PubMed ID: 17711713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.